Open veterinary journal · 2025
Sedative effects of detomidine and midazolam combination in horses.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gomes Érika Ribeiro, Felix Larissa Alexsandra, Gonzaga Lucas Wamser Fonseca, da Silva Naira Fernanda Dias, Soares Bruna Christina Fernandes, de Almeida João Vitor Fernandes Cotrim, Souza Gabriela Pereira, Pereira Rodrigo Norberto, Taffarel Marilda Onghero, Ferrante Marcos
Аннотация
BACKGROUND: The combination of detomidine and midazolam may provide safer sedation with muscle-relaxant effects, which are particularly necessary during standing procedures.
AIM: Thus, the objective of this study was to evaluate the sedative and muscle-relaxant effects of the detomidine/midazolam combination in horses through a pharmacodynamic study.
METHODS: Five horses were used and subjected to four experimental protocols: 15 µg/kg of detomidine (D15); a combination of detomidine (15 µg/kg) with 25 µg/kg (DM25), 50 µg/kg (DM50), or 75 µg/kg (DM75) of midazolam administered intravenously. The sedative and muscle-relaxant effects, as well as physiological parameters, were evaluated and statistically analyzed.
RESULTS: All protocols resulted in a decrease in head height, although no significant difference was observed among them. The acoustic stimulus response and tongue tone relaxation showed significant effects in the global analysis.
CONCLUSION: This study contributes to our understanding of the application of this combination in equine sedation protocols.
AIM: Thus, the objective of this study was to evaluate the sedative and muscle-relaxant effects of the detomidine/midazolam combination in horses through a pharmacodynamic study.
METHODS: Five horses were used and subjected to four experimental protocols: 15 µg/kg of detomidine (D15); a combination of detomidine (15 µg/kg) with 25 µg/kg (DM25), 50 µg/kg (DM50), or 75 µg/kg (DM75) of midazolam administered intravenously. The sedative and muscle-relaxant effects, as well as physiological parameters, were evaluated and statistically analyzed.
RESULTS: All protocols resulted in a decrease in head height, although no significant difference was observed among them. The acoustic stimulus response and tongue tone relaxation showed significant effects in the global analysis.
CONCLUSION: This study contributes to our understanding of the application of this combination in equine sedation protocols.